ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1135

Genome-Wide Meta-Analysis Identified Two Novel Variants Associated with Hallux Valgus

Liubov Arbeeva1, Braxton Mitchell2, Rebecca D. Jackson3, Michelle S. Yau4, Kathleen Ryan5, Yvonne M. Golightly6, Marian T. Hannan7, Amanda Nelson8, Joanne M. Jordan9 and Marc C. Hochberg2, 1TARC, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2School of Medicine, University of Maryland, Baltimore, MD, 3Ohio State University, Columbus, OH, 4Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, 5University of Maryland, Baltimore, MD, 6Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 7Institute for Aging Research, Hebrew SeniorLife & Harvard Medical School, Boston, MA, 8UNC School of Medicine, Chapel Hill, NC, 9Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, foot disorders and meta-analysis, Genetic Biomarkers, GWAS

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Hallux valgus (HV) is a common foot disorder that is highly heritable. A genome-wide association study (GWAS) conducted in 4,409 Caucasians from the Framingham Heart Study (FHS), the Genetics of Generalized Osteoarthritis (GOGO) Study, and the Johnston County Osteoarthritis (JoCoOA) Project did not find genome-wide significant (GWS) associations with HV in both gender-specific and sex-combined GWAS meta-analyses. In this analysis, we expand the sample by including data from Caucasians enrolled in the Osteoarthritis Initiative (OAI), and impute genotypes to the most current Haplotype Reference Consortium (HRC) reference panel. Our objective was to identify novel genetic variants associated with HV in this expanded sample of Caucasian adults with deeper imputation.

Methods: We included 5,925 participants of European Ancestry (EA) from four cohorts: FHS, GOGO, JoCoOA and OAI. HV was considered present if determined by trained examiners using validated protocol (FHS, GOGO, JoCoOA), or the participant reported a bunionectomy or Manchester grade (MG) was 3 or 4 in one or both feet (OAI). Controls included those without surgery and MG of one in both feet and those who did not meet examiner’s criterion. Genotyping was performed using commercially available arrays with imputation to the HRC reference panel. In OAI and JoCoOA, GWAS was performed using logistic regression models with additive genetic effects to examine association between SNPs and HV. For FHS and GOGO, GEE models were used to account for the within-family correlations. All models were adjusted for age, gender, body mass index and study specific covariates. After harmonization and quality control of GWAS results, fixed-effect inverse-variance weighted meta-analysis was conducted for the total sample and for men and women, separately. The genome-wide significance (GWS) level was set at p<5×10–8.

Results: Two intronic variants in the gene CLCA2 on chromosome 1 were GWS for HV: rs55807512 (OR=0.48, p=2.96E-09, MAF=0.04) and rs12124247 (OR=2.20, p=7.38E-09, MAF=0.03). The SNPs were in weak LD (r2=0.46). No other loci reached GWS although four variants of suggestive significance were located near the MIR2054 gene on chromosome 4. The association signals diminished in gender-specific analyses.

Conclusion: We identified two novel variants in the gene CLCA2 associated with HV.  This gene encodes a member of the calcium-activated chloride channel regulator family of proteins. CLCA2 plays a role in modulating chloride current across the plasma membrane in a calcium-dependent manner, and cell adhesion. These findings require replication.   


Disclosure: L. Arbeeva, None; B. Mitchell, None; R. D. Jackson, None; M. S. Yau, None; K. Ryan, None; Y. M. Golightly, None; M. T. Hannan, None; A. Nelson, GlaxoSmithKline, 5,Health press limited, 7; J. M. Jordan, None; M. C. Hochberg, None.

To cite this abstract in AMA style:

Arbeeva L, Mitchell B, Jackson RD, Yau MS, Ryan K, Golightly YM, Hannan MT, Nelson A, Jordan JM, Hochberg MC. Genome-Wide Meta-Analysis Identified Two Novel Variants Associated with Hallux Valgus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/genome-wide-meta-analysis-identified-two-novel-variants-associated-with-hallux-valgus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-meta-analysis-identified-two-novel-variants-associated-with-hallux-valgus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology